Related Experiment Video
Updated: Aug 5, 2026
09:38
Direct Reprogramming of Mouse Fibroblasts into Melanocytes
Published on: August 27, 2021
Vitiligo-Current Treatment Options and Future Perspectives
Aleksandra Wojno1, Agata Wojno1, Anna Karwowska1
1Student Research Group of Experimental Dermatology, University Centre of General Dermatology and Oncodermatology, Wroclaw Medical University, 50-556 Wrocław, Poland.
International Journal of Molecular Sciences
|July 28, 2026
Summary
Vitiligo treatment advances include targeted therapies like JAK inhibitors and immune modulators. Combining phototherapy with topical agents and exploring melanocyte transplantation offers promising, effective strategies for managing this chronic skin condition.
Area of Science:
- Dermatology
- Immunology
- Pharmacology
Background:
- Vitiligo is an autoimmune disorder causing melanocyte loss and skin depigmentation.
- Pathogenesis involves oxidative stress, immune dysregulation, and Janus kinase/signal transducer and activator of transcription (JAK/STAT) pathways.
Purpose of the Study:
- To review current vitiligo treatments.
- To outline promising future therapeutic directions for vitiligo.
Main Methods:
- Discussion of topical treatments (corticosteroids, calcineurin inhibitors, JAK inhibitors).
- Review of phototherapy modalities (NB-UVB, PUVA, excimer laser).
- Evaluation of surgical methods (cellular/tissue grafts) and combination therapies.
Main Results:
- Combination therapy (phototherapy + topical agents) improves repigmentation.
- JAK inhibitors show promise as targeted therapies.
- Immune-modulating preparations and melanocyte transplantation are highly effective.
Conclusions:
- Effective vitiligo management requires a multifaceted approach.
- Pharmacological, immunomodulatory, and regenerative interventions are key.
- Future treatments focus on targeted and regenerative strategies.
Related Concept Videos
01:30Skin Cancer
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
01:22iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:19Clinical Applications of Epidermal Stem Cells
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own EpiSCs...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...